Founded as the UK’s first not-for-profit, the CMC was launched in December 2018 at the Academy of Medical Sciences alongside an acclaimed report laying out a comprehensive blueprint for the implementation of medicinal cannabis access in the UK.
This spring, the CMC is expanding beyond its original focus on policy, research and advocacy to accelerate clinical trials, shape future regulation of CBD products and promote clinical education.
“This immediately strengthens the CMC’s capacity to shape the future of medicinal cannabis in the UK . We have adopted a ‘whole equation’ approach and will now be able to contribute across the spectrum of public policy, clinical research, medical education and public advocacy across all areas of regulation and law governing both high-THC unlicensed medicines (so-called CBMPs), and CBD products available without prescription to UK consumers,” said CMC Strategic Counsel, Steve Moore.
Read more here: https://www.prnewswire.com/news-releases/the-whole-equation-uk-medicinal-cannabis-industry-group-expanding-its-mission-to-accelerate-clinical-trials-regulate-cbd-and-promote-clinical-education-with-new-members-and-strengthening-of-leadership-team-300830084.html